


Slim Weight Loss Clinic operates in Tucson, Arizona, providing medical weight management services centered on GLP-1 receptor agonist therapies for adults struggling with obesity and weight-related metabolic conditions. The clinic structures treatment around three FDA-approved medications—Tirzepatide, Semaglutide, and Liraglutide—each selected based on individual patient metabolic profiles, weight loss goals, and medical history. Patients receive in-person consultations where providers assess body composition, review laboratory markers including hemoglobin A1c and lipid panels, and determine appropriate medication dosing protocols that align with current clinical guidelines for obesity pharmacotherapy.
The clinic's approach to Tirzepatide administration follows established titration schedules, beginning with lower doses and adjusting based on patient tolerance and weight loss response over 4-8 week intervals. Semaglutide protocols at Slim Weight Loss Clinic include both weekly subcutaneous injection options, with providers educating patients on proper injection technique, site rotation, and recognition of gastrointestinal side effects that commonly occur during dose escalation phases. Liraglutide serves as an alternative for patients who may benefit from daily dosing or have contraindications to dual-agonist medications, with the clinic monitoring cardiovascular parameters given the medication's effects on heart rate and blood pressure.
Treatment plans at the Tucson location incorporate regular follow-up appointments where providers track weight trends, adjust medication dosing, and address barriers to adherence including injection site reactions, nausea management, and dietary modifications that optimize GLP-1 therapy outcomes. The clinic requires patients to maintain consistent appointment schedules during the initial 12-16 weeks of treatment when most dose adjustments occur and metabolic adaptation is most pronounced. Providers discuss realistic weight loss expectations, typically 10-15% of baseline body weight over 6-12 months with GLP-1 therapy, and establish protocols for transitioning to maintenance dosing once target weight ranges are achieved.
Slim Weight Loss Clinic serves Tucson residents seeking medical intervention for obesity, particularly those with BMI over 30 or BMI over 27 with weight-related comorbidities such as type 2 diabetes, hypertension, or dyslipidemia. The in-person consultation model allows for hands-on assessment of injection technique, immediate response to patient questions about medication effects, and coordination with patients' primary care providers regarding adjustments to concurrent medications like insulin or blood pressure agents that may require modification as weight decreases. The clinic provides patients with structured monitoring tools to track weekly weight measurements, dietary intake patterns, and physical activity levels that complement pharmacologic intervention.
Patients at the clinic receive education on the mechanisms by which GLP-1 receptor agonists reduce appetite through hypothalamic signaling, slow gastric emptying, and improve insulin sensitivity, helping them understand the physiologic basis for their treatment rather than viewing medication as a standalone solution. The clinic's location in Tucson positions it to serve southern Arizona residents who prefer face-to-face medical consultations for weight management rather than telehealth models, with appointment availability structured to accommodate working adults seeking obesity treatment within their local community. Slim Weight Loss Clinic maintains protocols for medication prior authorization assistance, helping patients navigate insurance coverage for GLP-1 therapies and providing information on manufacturer savings programs when applicable.
Dr. Gary T. Marshall, MD, FACS
Surgeon
Dr. Gary T. Marshall practices in the New York City area and specializes in general surgery and critical care medicine.
Dr. Gary Kawesch, MD, FACS
Surgeon
Dr. Gary Kawesch practices in the Los Angeles area graduated with the highest Summa Cum Laude and Phi Beta Kappa honors from Yale University.
Dr. Thierry Jacquemin, International board-certified physician
Internal Medicine
Dr. Thierry Jacquemin has spent the last decade of his professional life helping his patients live better, smarter, longer, and prettier.
Topics Mentioned in Reviews
Semaglutide Weight Management
An injectable medication that mimics a hormone responsible for managing hunger signals and sugar levels.
Metformin Weight Management
An oral medication primarily prescribed to help manage blood sugar levels and assist in weight loss.
Liraglutide Weight Management
An injectable medication that helps regulate appetite and food intake.
Tirzepatide Weight Management
An injectable medication that mimics hormones involved in appetite regulation and glucose metabolism.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


